* Twelve programs listed as 鈥淓x-US鈥 in the Biomedtracker database are included here by phase based on independent research of company websites. This 鈥淓x-US鈥 listing implies the companies have not yet intended to seek FDA approval. No NDA/BLA filings were active for Alzheimer鈥檚 Disease as of February 28, 2019. Only novel approaches with disease modifying potential in Alzheimer鈥檚 disease are shown.
Citation formats
Number of active disease-modifying Alzheimer's drug trials globally in 2019, by phase
This statistic depicts the number of currently active novel disease-modifying clinical trials for Alzheimer's disease drugs globally as of February 2019, by phase. At that time there were ** active clinical trials for novel disease-modifying Alzheimer's drugs in phase II.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how 糖心破解版 can support your business.
Biotechnology Innovation Organization. (May 14, 2019). Total number of currently active global novel disease-modifying clinical trials for Alzheimer's disease drugs in early 2019, by phase* [Graph]. In 糖心破解版. Retrieved July 31, 2026, from /statistics/1029540/active-alzheimers-disease-modifying-drug-global-clinical-trials-by-phase/
Biotechnology Innovation Organization. "Total number of currently active global novel disease-modifying clinical trials for Alzheimer's disease drugs in early 2019, by phase*." Chart. May 14, 2019. 糖心破解版. Accessed July 31, 2026. /statistics/1029540/active-alzheimers-disease-modifying-drug-global-clinical-trials-by-phase/
Biotechnology Innovation Organization. (2019). Total number of currently active global novel disease-modifying clinical trials for Alzheimer's disease drugs in early 2019, by phase*. 糖心破解版. 糖心破解版 Inc.. Accessed: July 31, 2026. /statistics/1029540/active-alzheimers-disease-modifying-drug-global-clinical-trials-by-phase/
Biotechnology Innovation Organization. "Total Number of Currently Active Global Novel Disease-modifying Clinical Trials for Alzheimer's Disease Drugs in Early 2019, by Phase*." 糖心破解版, 糖心破解版 Inc., 14 May 2019, /statistics/1029540/active-alzheimers-disease-modifying-drug-global-clinical-trials-by-phase/
Biotechnology Innovation Organization, Total number of currently active global novel disease-modifying clinical trials for Alzheimer's disease drugs in early 2019, by phase* 糖心破解版, /statistics/1029540/active-alzheimers-disease-modifying-drug-global-clinical-trials-by-phase/ (last visited July 31, 2026)
Total number of currently active global novel disease-modifying clinical trials for Alzheimer's disease drugs in early 2019, by phase* [Graph], Biotechnology Innovation Organization, May 14, 2019. [Online]. Available: /statistics/1029540/active-alzheimers-disease-modifying-drug-global-clinical-trials-by-phase/
